AusPAR: Ixekizumab

Australian Public Assessment Report

AusPAR

AusPAR: Ixekizumab [PDF, 450.71 KB]

AusPAR: Ixekizumab [Word, 854.49 KB]

Attachment: Product Information for Ixekizumab [PDF, 627.45 KB]

Attachment: Product Information for Ixekizumab [Word, 480.57 KB]

Device/Product Name

Taltz

Active ingredients

Ixekizumab

AusPAR Date

22 June 2020

Published

6 July 2020

Submission Number

PM-2018-05753-1-3

Submission Type

Extension of indications

Decision

Approved